Abstract: [0037] The present invention relates to a composition comprising of EGCG, the active component extracted from green tea leaves and nutritional supplement such as Chromium polynicotinate for treating Alzheimer’s disease by arresting formation of beta amyloid proteins. Concentration of EGCG in the composition is at least 90% EGCG and ensures that the bioavailability of the product is extremely high.
DESC:as attached ,CLAIMS:What is claimed is
1. A composition for treating Alzheimer’s disease, the composition comprising:
a therapeutically effective amount of Epigallocatechin Gallate (EGCG) that cures the disease by preventing beta amyloid plaque formation in brain;
a therapeutically effective amount of chromium polynicotinate.
2. The composition according to claim 1, wherein the EGCG component of composition is extracted from green tea.
3. The composition according to claim 1, wherein the composition is in form of capsule or syrup or tablet for oral administration.
4. The composition according to claim 1, wherein the EGCG is the ester of epigallocatechin and gallic acid.
5. The composition according to claim 1, wherein the composition also increases tyrosine kinase activity to produce ATP to rejuvenate neurons.
6. The composition according to claim 1, wherein the chromium polynicotinate component of said composition increases glucose metabolism in brain.
7. The composition according to claim 1, wherein the composition treats said disease by promoting non amyloidogenic processing of amyloid precursor protein by up regulating beta secratase or normalize beta secratase production so that amyloid protein is not produced at all.
| # | Name | Date |
|---|---|---|
| 1 | 2687-CHE-2012 POWER OF ATTORNEY 04-07-2012.pdf | 2012-07-04 |
| 2 | 2687-CHE-2012 FORM-2 04-07-2012.pdf | 2012-07-04 |
| 3 | 2687-CHE-2012 FORM-1 04-07-2012.pdf | 2012-07-04 |
| 4 | 2687-CHE-2012 DESCRIPTION (PROVISIONAL) 04-07-2012.pdf | 2012-07-04 |
| 5 | 2687-CHE-2012 CORREPONDENCE OTHERS 04-07-2012.pdf | 2012-07-04 |
| 6 | Form 5.pdf | 2013-07-05 |
| 7 | Complete specification.pdf | 2013-07-05 |
| 8 | 2687-CHE-2012 FORM-3 23-07-2013.pdf | 2013-07-23 |
| 9 | 2687-CHE-2012 CORRESPONDENCE OTHERS 23-07-2013.pdf | 2013-07-23 |
| 10 | 2687-CHE-2012-FER.pdf | 2018-01-17 |
| 11 | 2687-CHE-2012-AbandonedLetter.pdf | 2018-08-28 |
| 1 | 2687_03-01-2018.pdf |